Parkinson's gene therapy AB-1005 trial moves forward in Europe
The first European participants in a Phase 2 trial of the Parkinson's gene therapy AB-1005 have been randomly assigned to treatment groups.| Parkinson's News Today
The first European participants in a Phase 2 trial of the Parkinson's gene therapy AB-1005 have been randomly assigned to treatment groups.| Parkinson's News Today
The nonprofit Healthwell Foundation has opened a fund to help offset Parkinson’s treatment costs for Medicare beneficiaries in the U.S.| Parkinson's News Today
Xingimaging and Synusight received a MFJJ grant to develop PET imaging technology that monitors toxic protein clumps in Parkinson's.| Parkinson's News Today
Parkinson's research and development moves far too slowly, says columnist Doc Irish, who argues for a more innovative and dynamic system.| Parkinson's News Today
Columnist Mary Beth Skylis shares instances where technology can support a better quality of life for Parkinson's disease patients.| Parkinson's News Today
A $697,000 MJFF grant and a renewed, five-year, $2.7 million NIH award will fund early Parkinson's research at the University of Wisconsin.| Parkinson's News Today
The Web's Daily Resource for Parkinson's News| Parkinson's News Today
The recipients of this year's grants include scientists and clinicians studying Parkinson’s biology, brain networks, and symptoms.| Parkinson's News Today
Parkinson’s patients and their care partners found several aspects of a personalized fall prevention program effective, despite barriers.| Parkinson's News Today
Seal Rock has joined an MJFF initiative to develop therapies targeting the LRRK2 gene, which can contribute to Parkinson’s development.| Parkinson's News Today
Having metabolic syndrome, a cluster of abnormalities characterized by abdominal obesity and high blood sugar, may increase Parkinson's risk.| Parkinson's News Today
Expanding access to specialist healthcare for Parkinson's is increasingly urgent as the number of patients rise in the U.S., researchers say.| Parkinson's News Today
Analyzing real-world patient data may help researchers better understand Parkinson’s causes, its early signs, and responses to therapy.| Parkinson's News Today
ENERGI-F705PD, a potential disease-modifying therapy for Parkinson’s, was found safe and well tolerated in healthy volunteers in a trial.| Parkinson's News Today
In a mouse model of Parkinson’s, continuous exposure to low-oxygen air eased or even reversed motor symptoms and slowed disease progression.| Parkinson's News Today
Parkinson's patients receiving brain stem cell transplant therapy may be able to take a less intensive immunosuppression regimen.| Parkinson's News Today
Insilico said it plans to ask the FDA this year for permission to move an AI-designed Parkinson's therapy into clinical trials.| Parkinson's News Today
A recent study confirmed columnist Mollie Lombardi's observations about the different ways women and men approach DBS surgery for Parkinson's.| Parkinson's News Today
Blocking the stress sensor GADD45G in astrocytes — star-shaped cells that support neurons — may be a therapeutic strategy for Parkinson’s.| Parkinson's News Today
The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.| Parkinson's News Today
Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the...| Parkinson's News Today
Casma Therapeutics will develop CSM-101 as a potential oral treatment for Parkinson's disease and Gaucher disease.| Parkinson's News Today
Routine evaluations and adjustments provide columnist Mollie Lombardi the best results with her deep brain stimulator.| Parkinson's News Today
Sleep disorders were mainly associated with Parkinson's motor symptoms and problems regulating involuntary bodily functions, a s tudy shows.| Parkinson's News Today
Columnist Mollie Lombardi hopes she doesn't experience the Parkinson's dementia that her grandpa had to endure.| Parkinson's News Today
Side-to-side eye movements reduced body sway in people with Parkinson's disease in a study of 10 people with Parkinson's and 11 without it.| Parkinson's News Today
Insightec's Exablate Neuro device is approved by the FDA for use by some Parkinson's patients with moderate-to-severe motor complications.| Parkinson's News Today
In a trial, once-daily buntanetap halted cognitive decline in early-stage Parkinson's and improved cognition in patients with mild dementia.| Parkinson's News Today
Parkinson’s patients show an inflammatory gut microbiome (bacterial population of the intestines) regardless of disease status or lifestyle.| Parkinson's News Today
Patricia Inacio is a science writer for Parkinson's News Today with a PhD in cell biology. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
Poor hand grip strength was tied to a higher risk of developing Parkinson’s in a U.K. study, especially among those with genetic risk factors.| Parkinson's News Today
The alpha-synuclein seed amplification assay, or alphaSyn-SAA, can detect Parkinson's disease with high accuracy, a new study reveals.| Parkinson's News Today
Marisa Wexler is a senior science writer for Parkinson's News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
Focused ultrasound, a minimally invasive technology, will soon be available at Vanderbilt to treat essential tremor and Parkinson’s disease.| Parkinson's News Today
Columnist Christine Scheer compares her Parkinson's symptoms today with their severity before she had deep brain stimulation surgery.| Parkinson's News Today
No description.| Parkinson's News Today
The Parkinson's Progression Markers Initiative, launched in 2010 to better understand and treat the disease, will recruit at sites in Canada.| Parkinson's News Today
The gut microbiome of Parkinson's patients shows substantial functional differences compared with that of healthy people, per a new study.| Parkinson's News Today
Lindsey Shapiro is a science writer for Parkinson's News Today with a PhD in neuroscience. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
Margarida Maia is a science writer for Parkinson's News Today with a PhD in biomedical sciences. She covers the latest news and information on a variety of Parkinson's topics.| Parkinson's News Today
Category archive page for News.| Parkinson's News Today
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto...| Parkinson's News Today
The American Parkinson Disease Association (APDA) has awarded $2.6 million to research projects aiming to better understand Parkinson's.| Parkinson's News Today
A history of upper gastrointestinal mucosal damage was associated with a 76% greater risk of subsequently developing Parkinson's disease.| Parkinson's News Today
The FDA issued a letter encouraging the use of an alpha-synuclein assay to improve the efficiency of clinical trials in Parkinson's disease.| Parkinson's News Today
UCF researchers have developed a biosensor that can rapidly detect and quantify dopamine levels in unprocessed blood samples.| Parkinson's News Today
Understanding and identifying epigenetic changes in blood samples from people with Parkinson’s disease may help assess the risk of dementia.| Parkinson's News Today
The clinical trial is assessing the safety of Allyx Therapeutics' ALX-001 versus a placebo when given to adults twice daily for 28 days.| Parkinson's News Today
